Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AerWave Medical has completed a first-in-human study (n=5) demonstrating procedural efficiency and feasibility for its ultrasound-based lung denervation system, targeting asthma and COPD. Initial data show disease-modifying potential with single-shot, circumferential ablation, reduced procedure time, and no need for fluoroscopy or ancillary devices. The platform is also being explored for applications in lung tumor ablation and lung volume reduction[3][4][8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AerWave Medical.